Aurora A kinase is frequently overexpressed in a variety of tumor types, including the prostate. However, the function of Aurora A in autophagy in prostate cancer has not been investigated. Here, we aimed to study the functioning mechanism and autophagy associated signaling pathways of Aurora A in prostate cancer.
METHODS:
To investigate the biological function of Aurora A, down-regulation of Aurora A was performed followed by functional testing assays. Immunohistochemistry was used to detect the expression of Aurora A in human prostate cancer specimens. CCK8, Transwell, flow cytometric analysis and measurement of tumor formation in nude mice were performed to test the effects of Aurora A down-regulation in vivo and in vitro. Signaling pathway analysis was performed by using Western blot. Autophagy activity was measured by monitoring the expression levels of LC3-II.
RESULTS:
Aurora A overexpression was significantly higher in human prostate cancer specimens than in BPH. Furthermore, Aurora A knockdown inhibited the proliferation of prostate cancer cells by suppressing the Akt pathway, indicating that Akt is a novel Aurora A substrate in prostate cancer. Additionally, Aurora A down-regulation prompts autophagy in prostate cancer cells. Most importantly, Aurora A ablation almost fully abrogates tumorigenesis in nude mice, suggesting that Aurora A is a key oncogenic effector in prostate cancer.
CONCLUSIONS:
Taken together, our data suggest that Aurora-A plays an important role in the suppression of autophagy by inhibiting the phosphorylation of Akt, which in turn prevents autophagy-induced apoptosis in prostate cancer.
SiegelR, MaJ, ZouZ, JemalA. Cancer statistics, 2014. CA: A Cancer Journal for Clinicians. 2014; 64(1): 9-29. doi: 10.3322/caac.21208.
2.
SiegelRL, MillerKD, JemalA. Cancer statistics, 2015. CA: A Cancer Journal for Clinicians. 2015; 65(1): 5-29. doi: 10.3322/caac.21254.
3.
SiegelRL, FedewaSA, MillerKD, Goding-SauerA, PinheiroPS, Martinez-TysonD et al. Cancer statistics for Hispanics/ Latinos, 2015. CA: A Cancer Journal for Clinicians. 2015; 65(6): 457-80. doi: 10.3322/caac.21314.
4.
DebesJD, TindallDJ. Mechanisms of androgen-refractory prostate cancer. The New England Journal of Medicine. 2004; 351(15): 1488-90. doi: 10.1056/NEJMp048178.
5.
AyalaG, ThompsonT, YangG, FrolovA, LiR, ScardinoP et al. High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research. 2004; 10(19): 6572-8. doi: 10.1158/1078-0432.CCR-04-0477.
6.
MartinNE, GerkeT, SinnottJA, StackEC, AndrenO, AnderssonSO et al. Measuring PI3K activation: clinicopathologic, immunohistochemical, and RNA expression analysis in prostate cancer. Molecular Cancer Research: MCR. 2015; 13(10): 1431-40. doi: 10.1158/1541-7786.MCR-14-0569.
7.
GloverDM, LeibowitzMH, McLeanDA, ParryH. Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles. Cell. 1995; 81(1): 95-105.
SourisseauT, ManiotisD, McCarthyA, TangC, LordCJ, AshworthA et al. Aurora-A expressing tumour cells are deficient for homology-directed DNA double strand-break repair and sensitive to PARP inhibition. EMBO Molecular Medicine. 2010; 2(4): 130-42. doi: 10.1002/emmm.201000068.
10.
WangG, JiangQ, ZhangC. The role of mitotic kinases in coupling the centrosome cycle with the assembly of the mitotic spindle. Journal of Cell Science. 2014; 127(Pt 19): 4111-22. doi: 10.1242/jcs.151753.
11.
BarberTD, McManusK, YuenKW, ReisM, ParmigianiG, ShenD et al. Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proceedings of the National Academy of Sciences of the United States of America. 2008; 105(9): 3443-8. doi: 10.1073/pnas.0712384105.
12.
LiJJ, WerohaSJ, LingleWL, PapaD, SalisburyJL, LiSA. Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101(52): 18123-8. doi: 10.1073/pnas.0408273101.
13.
MalumbresM, Perez de CastroI. Aurora kinase A inhibitors: promising agents in antitumoral therapy. Expert Opinion on Therapeutic Targets. 2014; 18(12): 1377-93. doi: 10.1517/14728222.2014.956085.
14.
SmithSL, BowersNL, BetticherDC, GautschiO, RatschillerD, HobanPR et al. Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability. British Journal of Cancer. 2005; 93(6): 719-29. doi: 10.1038/sj.bjc.6602779.
15.
VischioniB, OudejansJJ, VosW, RodriguezJA, GiacconeG. Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients. Molecular Cancer Therapeutics. 2006; 5(11): 2905-13. doi: 10.1158/1535-7163.MCT-06-0301.
16.
KatayamaH, SasaiK, KawaiH, YuanZM, BondarukJ, SuzukiF et al. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nature Genetics. 2004; 36(1): 55-62. doi: 10.1038/ng1279.
LevineB, KroemerG. Autophagy in the pathogenesis of disease. Cell. 2008; 132(1): 27-42. doi: 10.1016/j.cell.2007.12.018.
19.
GiatromanolakiA, SivridisE, MendrinosS, KoutsopoulosAV, KoukourakisMI. Autophagy proteins in prostate cancer: Relation with anaerobic metabolism and Gleason score. Urologic Oncology. 2014; 32(1): 39e11-8. doi: 10.1016/j.urolonc.2013.04.003.
20.
ShuklaS, MaclennanGT, HartmanDJ, FuP, ResnickMI, GuptaS. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. International Journal of Cancer. 2007; 121(7): 1424-32. doi: 10.1002/ijc.22862.
21.
ZhengF, YueC, LiG, HeB, ChengW, WangX et al. Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype. Nature Communications. 2016; 7: 10180. doi: 10.1038/ncomms10180.
22.
SchneppRW, KhuranaP, AttiyehEF, RamanP, ChodoshSE, OldridgeDA et al. A LIN28B-RAN-AURKA signaling network promotes neuroblastoma tumorigenesis. Cancer Cell. 2015; 28(5): 599-609. doi: 10.1016/j.ccell.2015.09.012.
23.
MichaelisM, SeltF, RothweilerF, LoschmannN, NusseB, DirksWG et al. Aurora kinases as targets in drug-resistant neuroblastoma cells. PloS One. 2014; 9(9): e108758. doi: 10.1371/journal.pone.0108758.
24.
PickhardA, SieglM, BaumannA, HuhnM, WirthM, ReiterR et al. The response of head and neck squamous cell carcinoma to cetuximab treatment depends on Aurora kinase A polymorphism. Oncotarget. 2014; 5(14): 5428-38. doi: 10.18632/oncotarget.2117.
25.
LeeEC, FrolovA, LiR, AyalaG, GreenbergNM. Targeting Aurora kinases for the treatment of prostate cancer. Cancer Research. 2006; 66(10): 4996-5002. doi: 10.1158/0008-5472.CAN-05-2796.
26.
SunK, GuoXL, ZhaoQD, JingYY, KouXR, XieXQ et al. Paradoxical role of autophagy in the dysplastic and tumor-forming stages of hepatocarcinoma development in rats. Cell Death & Disease. 2013; 4: e501. doi: 10.1038/cddis.2013.35.
27.
XuY, XiaX, PanH. Active autophagy in the tumor microenvironment: A novel mechanism for cancer metastasis. Oncology Letters. 2013; 5(2): 411-6. doi: 10.3892/ol.2012.1015.
28.
JiaoY, ZhangW, LiuJ, NiW, XuW, JinJ et al. Telomere attrition and chromosome instability via downregulation of TRF2 contributes to arsenic trioxide-induced apoptosis of human T-Cell leukemia cell line molt-4 cells. Cancer Biology & Therapy. 2007; 6(8): 1186-92.
29.
KlionskyDJ, AbdallaFC, AbeliovichH, AbrahamRT, Acevedo-ArozenaA, AdeliK et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012; 8(4): 445-544.
30.
SongG, OuyangG, BaoS. The activation of Akt/PKB signaling pathway and cell survival. Journal of Cellular and Molecular Medicine. 2005; 9(1): 59-71.
31.
KimJ, KunduM, ViolletB, GuanKL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nature Cell Biology. 2011; 13(2): 132-41. doi: 10.1038/ncb2152.
32.
LiuB, BaoJK, YangJM, ChengY. Targeting autophagic pathways for cancer drug discovery. Chinese Journal of Cancer. 2013; 32(3): 113-20. doi: 10.5732/cjc.012.10010.
33.
WangRC, WeiY, AnZ, ZouZ, XiaoG, BhagatG et al. Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science. 2012; 338(6109): 956-9. doi: 10.1126/science.1225967.
34.
TalaberG, MiklossyG, OaksZ, LiuY, ToozeSA, ChudakovDM et al. HRES-1/Rab4 promotes the formation of LC3(+) autophagosomes and the accumulation of mitochondria during autophagy. PloS One. 2014; 9(1): e84392. doi: 10.1371/journal.pone.0084392.
35.
LeeYJ, HahYJ, KangYN, KangKJ, HwangJS, ChungWJ et al. The autophagy-related marker LC3 can predict prognosis in human hepatocellular carcinoma. PloS One. 2013; 8(11): e81540. doi: 10.1371/journal.pone.0081540.
36.
KaserA, BlumbergRS. Autophagy, microbial sensing, endoplasmic reticulum stress, and epithelial function in inflammatory bowel disease. Gastroenterology. 2011; 140(6): 1738-47. doi: 10.1053/j.gastro.2011.02.048.
37.
LiJP, YangYX, LiuQL, PanST, HeZX, ZhangX et al. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. Drug Design, Development and Therapy. 2015; 9: 1627-52. doi: 10.2147/DDDT.S75378.
38.
LuQ, LiuZ, LiZ, ChenJ, LiaoZ, WuWR et al. TIPE2 Overexpression Suppresses the Proliferation, Migration, and Invasion in Prostate Cancer Cells by Inhibiting PI3K/Akt Signaling Pathway. Oncology Research. 2016; 24(5): 305-13. doi: 10.3727/096504016X14666990347437.
